Macintosh Blade Size for Endotracheal Intubation in Operative Rooms
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jan 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the best size of the Macintosh blade used for endotracheal intubation, which is a common procedure where a tube is inserted into the windpipe to help patients breathe during surgery. Researchers want to find out which blade size works best to reduce complications during this procedure. The trial is not yet recruiting participants, but it is aimed at adults aged 18 and older who are admitted to participating operating rooms and need mechanical ventilation.
To be eligible for the study, participants must be covered by public health insurance and provide written consent to join the study. However, people who might have a difficult time with intubation or who refuse to participate will not be included. If you join the study, you can expect to help researchers learn more about the best practices for intubation, which could improve safety and outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients must be admitted in a participating operative room and require mechanical ventilation through an orotracheal tube.
- • Adult (age ≥ 18 years)
- • Subjects must be covered by public health insurance
- • Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency.
- Exclusion Criteria:
- • Anticipated difficult intubation requiring videolaryngoscopy or other technic in first place
- • Nasotracheal intubation
- • Refusal of study participation or to pursue the study by the patient
- • Absence of coverage by the French statutory healthcare insurance system
- • Protected person
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Thomas Godet, MD, PhD
Principal Investigator
Clermont-Ferrand University Hospitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported